Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Grupo Espanol de Investigacion en Sarcomas
ClinicalTrials.gov Identifier:
NCT01692496
First received: September 14, 2012
Last updated: February 18, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)